2021
DOI: 10.1007/s00068-021-01631-1
|View full text |Cite
|
Sign up to set email alerts
|

Multicentre cohort study of acute cholecystitis management during the COVID-19 pandemic

Abstract: Purpose To analyse acute cholecystitis (AC) management during the first pandemic outbreak after the recommendations given by the surgical societies estimating: morbidity, length of hospital stay, mortality and hospital-acquired SARS-CoV-2 infection rate. Methods Multicentre-combined (retrospective-prospective) cohort study with AC patients in the Community of Madrid between 1st March and 30th May 2020. 257 AC patients were involved in 16 public hospital. Multivariant binomial logistic regression (MBLR) was app… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(15 citation statements)
references
References 22 publications
0
15
0
Order By: Relevance
“…The significant decrease in the number of cholecystectomies in the present study is in line with an international survey including 14 countries [ 25 ], where the majority (72%) of hepato-pancreato-biliary surgeons reported an “alarming decrease” in the number of cholecystectomies during the pandemic. An increase in non-surgical treatment for acute cholecystitis was also reported by multicenter studies from the U.K. and Spain [ 26 , 27 ], although a multisocietary position statement concluded that laparoscopic cholecystectomy remains the treatment of choice for acute cholecystitis even during the COVID-19 pandemic [ 28 ]. Whether the choice of non-surgical treatment for complicated gallstone disease negatively impacted the outcomes of patients warrants further investigation.…”
Section: Discussionmentioning
confidence: 99%
“…The significant decrease in the number of cholecystectomies in the present study is in line with an international survey including 14 countries [ 25 ], where the majority (72%) of hepato-pancreato-biliary surgeons reported an “alarming decrease” in the number of cholecystectomies during the pandemic. An increase in non-surgical treatment for acute cholecystitis was also reported by multicenter studies from the U.K. and Spain [ 26 , 27 ], although a multisocietary position statement concluded that laparoscopic cholecystectomy remains the treatment of choice for acute cholecystitis even during the COVID-19 pandemic [ 28 ]. Whether the choice of non-surgical treatment for complicated gallstone disease negatively impacted the outcomes of patients warrants further investigation.…”
Section: Discussionmentioning
confidence: 99%
“…The standard treatment for acute cholecystitis is laparoscopic cholecystectomy, and conservative treatment, such as percutaneous cholecystostomy, can be performed in patients in the high-risk group for surgery. However, during the pandemic period, percutaneous cholecystostomy was preferred, in order to avoid laparoscopic surgery, even if the patient was not in a poor general condition ( 34 36 ).…”
Section: Discussionmentioning
confidence: 99%
“…This approach consisted of either conservative management and sole use of antibiotics for 127 (58%) patients or PC for 33 (15%) patients. Martínez Caballero et al ( 18 ) did not report exact numbers on all three categories, but it clearly indicates a shift toward conservative management. On the other hand, surgery was the selected approach for 139/475 patients (29.2%).…”
Section: Resultsmentioning
confidence: 98%